Giles Gwinnett is a qualified journalist and has been a reporter for a number of regional newspapers and for a press agency. He was formerly a news analyst on the German team at Thomson Financial, now Thomson Reuters. He has a bachelor’s degree in English Literature and German and a master's in Film Studies.
The company discovered an efficient way to infuse aqueous solutions with oil-based extracts, it said.
LeanLife delivers high concentration levels of omega-3 as a nutritional additive, it said
It was the first Canadian company to win a top strain at an international competition with 'BC God Bud'
Revenue came in at around C$5.4mln for the 12 months to end April, compared to around C$2.6mln for 2017 - a 107% increase
The program's remit is to ensure that the Canadian life sciences sector has the executive talent needed
Cote retired from the sport last year after a successful career of 15 years
The group issued around 2.43mln units at C$0.21 each for gross proceeds of $511,499.94
Last week, the firm revealed it had completed its acquisition of cannabis strain-focused BC Bud Depot (BCBD)
Analyst Craig Stanley, back from a site visit, repeated a 'buy' on the stock
The Tiple Block acreage is adjacent to Geopark’s prolific Llanos 34 Block
A look at some of the analyst comment on North America listed stocks on Monday
A look at some analyst views from around the City on Friday